Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17393012rdf:typepubmed:Citationlld:pubmed
pubmed-article:17393012lifeskim:mentionsumls-concept:C1882071lld:lifeskim
pubmed-article:17393012lifeskim:mentionsumls-concept:C0042971lld:lifeskim
pubmed-article:17393012lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:17393012lifeskim:mentionsumls-concept:C0205177lld:lifeskim
pubmed-article:17393012lifeskim:mentionsumls-concept:C1979891lld:lifeskim
pubmed-article:17393012lifeskim:mentionsumls-concept:C1706853lld:lifeskim
pubmed-article:17393012pubmed:issue4lld:pubmed
pubmed-article:17393012pubmed:dateCreated2007-3-29lld:pubmed
pubmed-article:17393012pubmed:abstractTextThe large glycoprotein von Willebrand factor (VWF) is involved in the initial haemostatic reaction mediating the interaction between platelets and the injured vessel wall. It has been demonstrated that unusually large VWF (ULVWF) multimers after being released from endothelium are capable of developing elongated membrane-anchored strings that are hyperactive to bind platelets. In the present study we investigated whether soluble plasma-derived VWF is competent to develop similar thrombotically active multimers. We demonstrated that soluble VWF multimers isolated from human plasma self-assemble to a network of fibers immobilized on a collagen matrix and are functionally active to bind platelets. Formation of these VWF fibers depends on shear flow, concentration of soluble VWF, and a suitable binding surface. Self-assembly of soluble VWF does not require the presence of cellular membrane ligands. The network of fibers is subjected to rapid degradation by proteolytic activity of plasma ADAMTS-13. Atomic force microscopy images elucidate the nanostructure of VWF fibers and illustrate self-association and -aggregation of several filamentous multimers. Together, these results suggest that circulating VWF can contribute to a formation of hyperactive VWF fibers on exposed subendothelial collagen during vascular injury.lld:pubmed
pubmed-article:17393012pubmed:languageenglld:pubmed
pubmed-article:17393012pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17393012pubmed:citationSubsetIMlld:pubmed
pubmed-article:17393012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17393012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17393012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17393012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17393012pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17393012pubmed:statusMEDLINElld:pubmed
pubmed-article:17393012pubmed:monthAprlld:pubmed
pubmed-article:17393012pubmed:issn0340-6245lld:pubmed
pubmed-article:17393012pubmed:authorpubmed-author:GoergeTobiasTlld:pubmed
pubmed-article:17393012pubmed:authorpubmed-author:OssigRainerRlld:pubmed
pubmed-article:17393012pubmed:authorpubmed-author:OberleithnerH...lld:pubmed
pubmed-article:17393012pubmed:authorpubmed-author:SchneiderStef...lld:pubmed
pubmed-article:17393012pubmed:authorpubmed-author:SchneiderMatt...lld:pubmed
pubmed-article:17393012pubmed:authorpubmed-author:SchillersHerm...lld:pubmed
pubmed-article:17393012pubmed:authorpubmed-author:BargAlexejAlld:pubmed
pubmed-article:17393012pubmed:issnTypePrintlld:pubmed
pubmed-article:17393012pubmed:volume97lld:pubmed
pubmed-article:17393012pubmed:ownerNLMlld:pubmed
pubmed-article:17393012pubmed:authorsCompleteYlld:pubmed
pubmed-article:17393012pubmed:pagination514-26lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:meshHeadingpubmed-meshheading:17393012...lld:pubmed
pubmed-article:17393012pubmed:year2007lld:pubmed
pubmed-article:17393012pubmed:articleTitleSoluble plasma-derived von Willebrand factor assembles to a haemostatically active filamentous network.lld:pubmed
pubmed-article:17393012pubmed:affiliationInstitute of Physiology II - Nanolab, University of Muenster, Muenster, Germany.lld:pubmed
pubmed-article:17393012pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17393012pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:17393012pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:7450entrezgene:pubmedpubmed-article:17393012lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17393012lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17393012lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17393012lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17393012lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17393012lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17393012lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17393012lld:pubmed